METHODS FOR PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA
摘要
The method for prognosis of a patient suffering from diffuse large B-cell lymphoma (DLBCL) comprises determining in a sample from said patient the level of at least one biomarker selected from the group consisting of VEGF, BCL6, CD68, CD20, and combinations thereof.
申请公布号
CA2848365(A1)
申请公布日期
2013.03.21
申请号
CA20122848365
申请日期
2012.09.12
申请人
EUROPATH BIOSCIENCES, S.L.;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA (FCRB)
发明人
DONOVAN, MICHAEL J.;ERILL SAGALES, NADINA;COLOMER VALERO, ANNA;PUIG, PERE;CAMPO, ELIAS;COLOMO, LUIS
